Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Safety Profile of Three Escalating Radioactivity Levels of 32P BioSilicon Delivered With the SIMPL Needle as Intratumoural Implantations in Patients With Unresectable Hepatocellular Carcinoma

NCT00247260 is registered in ClinicalTrials.gov with pSiVida Limited as lead sponsor.

NCT NCT00247260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00247260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Safety Profile of Three Escalating Radioactivity Levels of 32P BioSilicon Delivered With the SIMPL Needle as Intratumoural Implantations in Patients With Unresectable Hepatocellular Carcinoma
Lead sponsor
pSiVida Limited
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2005
Completion date
February 28, 2007
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer